| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/07/2009 | US20090118303 Serotonin 5-ht3 receptor agonist |
| 05/07/2009 | US20090118298 Octahydropentalene compounds as chemokine receptor antagonists |
| 05/07/2009 | US20090118291 Histone deacetylase inhibitors |
| 05/07/2009 | US20090118290 Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity |
| 05/07/2009 | US20090118284 Novel compounds that are ERK inhibitors |
| 05/07/2009 | US20090118279 Compound containing basic group and use thereof |
| 05/07/2009 | US20090118275 Thiazolopyrimidine p13k inhibitor compounds and methods of use |
| 05/07/2009 | US20090118274 Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s |
| 05/07/2009 | US20090118273 Compounds and Compositions as Protein Kinase Inhibitors |
| 05/07/2009 | US20090118271 Preventive or Therapeutic Agents for Pancreatic Cancer, Ovarian Cancer, or Liver Cancer Comprising a Novel Water-Soluble Prodrug |
| 05/07/2009 | US20090118268 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
| 05/07/2009 | US20090118263 Novel Adenine Compound |
| 05/07/2009 | US20090118261 Quinazolinone derivatives and their use as b-raf inhibitors |
| 05/07/2009 | US20090118215 Bioresorbable Controlled-Release Composition |
| 05/07/2009 | US20090118208 Composition and methods of RNAI therapeutics for treatment of cancer and other neovascularization diseases |
| 05/07/2009 | US20090118191 Anti-Antiogenic Fragments of Pigment Epithelium-Derived Factor (PEDF) |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118175 Compositions and Methods for Detection, Prognosis and Treatment of Breast Cancer |
| 05/07/2009 | US20090118164 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090117566 Compositions and methods for the diagnosis and treatment of tumor |
| 05/07/2009 | US20090117215 Extract of ceratonia siliqua leaves and pods containing polyphenols with antioxidant and antitumor activities |
| 05/07/2009 | US20090117204 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use |
| 05/07/2009 | US20090117199 Method of treatment of cancer |
| 05/07/2009 | US20090117197 Compositions and methods for ameliorating cachexia |
| 05/07/2009 | US20090117193 Compositions Comprising an Active Agent |
| 05/07/2009 | US20090117177 Echogenic microbubbles and microemulsions for ultrasound-enhanced nanoparticle-mediated delivery of agents |
| 05/07/2009 | US20090117176 Anticancer Treatments |
| 05/07/2009 | US20090117168 Device and method for attaracting diseased cells and foreign substances |
| 05/07/2009 | US20090117153 Disulfide Trap MHC Class I Molecules and Uses Therefor |
| 05/07/2009 | US20090117143 Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens |
| 05/07/2009 | US20090117134 Truncated EGF Receptor |
| 05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
| 05/07/2009 | US20090117132 Anti-Ctla-4 Antibody and Cpg-Motif-Containing Synthetic Oligodeoxynucleotide Combination Therapy for Cancer Treatment |
| 05/07/2009 | US20090117127 Novel Compounds and Methods for Their Production |
| 05/07/2009 | US20090117125 Synthesis of 8h-3a-aza-cyclopenta[a]indenes and 5,10-dihydropyrrolo[1,2-b]isoquinolines derivatives and their use as antitumor therapeutic agents |
| 05/07/2009 | US20090117119 Rtef-1 variants and the use thereof for inhibition of angiogenesis |
| 05/07/2009 | US20090117117 Targeting abcb5 for cancer therapy |
| 05/07/2009 | US20090117116 Immunogenic peptides and methods of use for treating and preventing cancer |
| 05/07/2009 | US20090117108 Gene Engineering Recombinant Anti-CEA, Anti-CD3, And Anti-CD28 Single-Chain Tri-Specific Antibody |
| 05/07/2009 | US20090117100 Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates |
| 05/07/2009 | US20090117089 Glycolipids and analogues thereof as antigens for nk t cells |
| 05/07/2009 | US20090117084 Bacteriophage and prophage proteins in cancer gene therapy |
| 05/07/2009 | US20090117083 Immunomodulatory alkaloids |
| 05/07/2009 | US20090117082 Reovirus for the Treatment of Cellular Proliferative Disorders |
| 05/07/2009 | US20090117081 Parvovirus methods and compositions for killing neoplastic cells |
| 05/07/2009 | US20090117077 Polyethylene glycol-interferon alpha conjugate |
| 05/07/2009 | US20090117076 Methods For Treating Tumor Cells |
| 05/07/2009 | US20090117074 Sulfonylpyrroles as Histone Deacetylase Inhibitors |
| 05/07/2009 | US20090117053 Local delivery of 5-aminolevulinic-acid based compounds to tissues and organs for diagnostic and therapeutic purposes |
| 05/07/2009 | US20090117050 Stem cell targeting of cancer, methods and compositions therefor |
| 05/07/2009 | US20090117042 Imaging agents and methods of imaging NAALADase or PSMA |
| 05/07/2009 | US20090117037 Methods Of Treatment Using CTLA-4 Antibodies |
| 05/07/2009 | US20090117035 Temperature-Sensitive Liposomal Formulation |
| 05/07/2009 | US20090117034 Microorganisms for imaging and/or treatment of tumors |
| 05/07/2009 | DE4042752B4 Verfahren zur Herstellung von Mikropartikeln, welche einen Wirkstoff in einem bioabbaubaren polymeren Träger enthalten Process for the preparation of microparticles containing an active agent in a biodegradable polymeric carrier, |
| 05/07/2009 | DE102007052119A1 New coumermycin A1-derivative, useful as biologically active substance and as antibiotics or cytostatics, and for preventing diseases caused by bacteria or tumor |
| 05/07/2009 | CA2742252A1 Cytidine analogs for treatment of myelodysplastic syndromes |
| 05/07/2009 | CA2740310A1 Altered cadherin processing in tumor cells |
| 05/07/2009 | CA2704517A1 Use of cfms inhibitor for treating or preventing bone cancer and the bone loss and bone pain associated with bone cancer |
| 05/07/2009 | CA2704190A1 Nell-1 compositions |
| 05/07/2009 | CA2704124A1 Method for inhibiting angiogenesis or for treatment of cancer |
| 05/07/2009 | CA2704043A1 Targeting micrornas for the treatment of liver cancer |
| 05/07/2009 | CA2703981A1 Heterocyclic urea and thiourea derivatives and methods of use thereof |
| 05/07/2009 | CA2703980A1 Diamido thiazole derivatives as protein kinase inhibitors |
| 05/07/2009 | CA2703979A1 Heterocyclic ether and thioether derivatives and methods of use thereof |
| 05/07/2009 | CA2703978A1 Thiazole derivatives as protein kinase inhibitors |
| 05/07/2009 | CA2703780A1 Drug for prophylaxis or treatment of cancer |
| 05/07/2009 | CA2703767A1 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents |
| 05/07/2009 | CA2703257A1 Benzomorpholine derivatives and methods of use |
| 05/07/2009 | CA2700433A1 Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6) |
| 05/07/2009 | CA2695628A1 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 05/06/2009 | EP2056111A1 Methods and compositions for regulating protein-protein interactions |
| 05/06/2009 | EP2055705A1 Compound having cyclic group bound thereto through spiro binding and use thereof |
| 05/06/2009 | EP2055697A1 Design and synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (BPU) sulfur analogs |
| 05/06/2009 | EP2055313A1 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody |
| 05/06/2009 | EP2055312A1 Molecular antigen array presenting amyloid beta |
| 05/06/2009 | EP2055310A1 Further use of protein kinase N beta |
| 05/06/2009 | EP2054894A2 Composition apparatus and method for use in imaging |
| 05/06/2009 | EP2054444A2 Antibodies to erbb2 |
| 05/06/2009 | EP2054443A2 Antibodies to an epitope of agr2, assays and hybridomas |
| 05/06/2009 | EP2054425A1 Osmium compounds |
| 05/06/2009 | EP2054424A1 Vinyl phosphonate lysophosphatidic acid receptor antagonists |
| 05/06/2009 | EP2054419A2 Pyrimidinone derivatives and their use as a drug |
| 05/06/2009 | EP2054418A1 Dihydrothieno pyrimidines as akt protein kinase inhibitors |
| 05/06/2009 | EP2054417A2 Fused thiophene derivatives as mek inhibitors |
| 05/06/2009 | EP2054406A1 Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy |
| 05/06/2009 | EP2054398A1 New heterocyclic compounds containing nitrogen atoms or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same for treatment of cancer |
| 05/06/2009 | EP2054393A1 Crystalline erlotinib |
| 05/06/2009 | EP2054072A1 Heat processed vegetabilic fiber preparation and its use as inhibitor of the effects of carcinogenic substances in humans or animals |
| 05/06/2009 | EP2054063A2 4-aminoquinazoline derivatives and methods of use thereof |
| 05/06/2009 | EP2054061A2 Combination therapy |
| 05/06/2009 | EP2054060A1 Fluorinated ligands for targeting peripheral benzodiazepine receptors |
| 05/06/2009 | EP2054059A2 Triazole compounds that modulate hsp90 activity |
| 05/06/2009 | EP2054058A2 Inhibitors of pyruvate kinase and methods of treating disease |
| 05/06/2009 | EP2003211A9 Process for producing optically active (s)-7-hydroxy-6-methylheptane-2-one and precursor thereof |
| 05/06/2009 | EP1828185B1 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors |
| 05/06/2009 | EP1827500B1 Pegylated liposomal doxorubicin in combination with ecteinescidin 743 |
| 05/06/2009 | EP1732938B1 Organophosphorous indazole derivatives and use thereof as protein kinase inhibitors |
| 05/06/2009 | EP1656160B1 Radioimmunoconjugates for targeted alpha therapy |